Global Amblyopia Treatment Market, By Type (Strabismic Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, Others), Diagnosis (Visual Acuity Test and Photo screening), Treatment (Glasses, Eye Patches, Atropine Drops, Surgery), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) – Industry Trends and Forecast to 2030.
Amblyopia Treatment Market Analysis and Size
Poor sight occurs in one eye during infancy or childhood and worsens with time if not treated. The most common cause of this diseased condition is generally other vision problems. Leading market players in the global amblyopia treatment market are building their production capabilities because of the rising hypermetropia and myopia worldwide. These efforts are assisting companies in fulfilling the collective demand for prescription glasses needed for such eye disorders.
Data Bridge Market Research analyses a growth rate in the global amblyopia treatment market in the forecast period 2023-2030. The expected CAGR of global amblyopia treatment market is tend to be around 4.30% in the mentioned forecast period. The market was valued at USD 3724.2 million in 2022, and it would grow upto USD 5215.64 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Amblyopia Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Strabismic Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, Others), Diagnosis (Visual Acuity Test and Photo screening), Treatment (Glasses, Eye Patches, Atropine Drops, Surgery), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Novartis AG (Switzerland), Abbvie,Inc (U.S.), Bausch Health Companies Inc (Canada), Integra LifeSciences (U.S.), Alcon (U.S.), Astellas Pharma Inc. (Japan), Takeda Pharmaceutical Company Limited (Japan), Vertex Pharmaceuticals Incorporated (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Fresnel Prism and Lens Co (U.S.), Lancastle International Ltd (U.K.), Good-Lite (Scotland), RevitalVision (U.S.), Vivid Vision, Inc (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Amblyopia is also termed as lazy eye syndrome, wherein reduced vision in one eye is caused by abnormal visual development very early in life. The disease usually develops from the onset of birth and up to 7 years. It is the primary cause of reduced vision among children. Rarely, lazy eye affects both eyes. The eye with poorer vision can generally be corrected with glasses or contact lenses, or sometimes with patching therapy.
Global Amblyopia Treatment Market Dynamics
Drivers
- Rising Incidence of Amblyopia
Amblyopia is quite frequent during childhood, with a global occurrence ranging between 0.2% and 6.2%. According to the journal published in Karger International, the latest meta-analysis article estimated 99.2 million people with amblyopia worldwide in 2019, possibly rising to 175.2 million by 2030 and 221.9 million by 2040. Thus, this boosts the market growth.
- Higher Drug Approvals
Several key market players focus on launching technologically advanced products to treat amblyopia. This is expected to increase the global amblyopia treatment market during the forecast period. For instance, in March 2021, NovaSight received the Food and Drug Administration 510(k) clearance for CureSight for the treatment of amblyopia. The device helps in training the brain to use both eyes simultaneously, while the user watches videos through 3D glasses.
Opportunities
- Use of Pure Cotton Amblyopia Eye Patches
Pure cotton amblyopia eye patches for glasses are expanding the growth of the amblyopia treatment market. These products are mainly targeted for the treatment of strabismic amblyopia in children. All these products are being made available through various e-commerce platforms to create revenue streams. Numerous manufacturers are manufacturing pure cotton amblyopia eye patches that prevent any stimulation contacting with the soft skin and contain hygienic properties. Therefore, all these factors boost the growth of the market.
- Increasing Demand of Video Games as Treatment Option
Video games are growing as an innovative treatment option for amblyopia. Investors in the amblyopia treatment market are growing awareness about the proper application of video games at an early age in children by improving the connections between the brain and the eye. It has been witnessed that wearing an eye patch may not help the eyes to learn to work together, numerous companies in the amblyopia treatment market are mounting their focus in video games to promptly appeal to the interest of children and parents.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified healthcare professional who are unable to treat the patients with appropriate treatments could limit the growth of the global amblyopia treatment market over a forecast period.
- High Cost
The huge expenditure required for setting up these techniques impede the market growth. Several market players make huge investments in developing new and advanced machines to increase the process; in return, the cost is increased.
This global amblyopia treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global amblyopia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Amblyopia Treatment Market
The American Academy of Ophthalmology (AAO) has recommended ophthalmologists to stop providing non-urgent care during the ongoing pandemic. The institute has also provided a series of urgent and emergent procedures required to solve potential sight-threatening conditions. Such findings are affecting and boosting the growth of the amblyopia treatment market. Though eye diseases legit involve a fatal outcome, potential morbidity in patients has obliged companies in the amblyopia treatment market to maintain constant supply chains of eye patches, eyeglasses, and other treatment options. Investors are gaining awareness about publications that share recommendations on treating eye diseases such as amblyopia during the COVID-19 outbreak. Though, there is a need for more specific recommendations concerning to the amblyopia treatment.
Recent Development
- In October 2021, HOYA Vision Care, announced a partnership with Orbis International, which is a global organization that mentors, trains, and inspires local eye care professionals to save sight in their communities. The main aim behind this strategic partnership is to bridge the vision care gap around the world.
Global Amblyopia Treatment Market
The global amblyopia treatment market is segmented on the basis of type, diagnosis, treatment, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Strabismic Amblyopia
- Refractive Amblyopia
- Deprivation Amblyopia
- Others
Diagnosis
- Visual Acuity Test
- Photo screening
Treatment
- Glasses
- Eye Patches
- Atropine Drops
- Surgery
End User
- Hospital/Clinical Laboratories
- Physician Offices
- Reference Laboratories
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Other
Global Amblyopia Treatment Market Regional Analysis/Insights
The global amblyopia treatment market is analyzed and market size insights and trends are provided by type, diagnosis, treatment , end-user and distribution channel as referenced above.
The major countries covered in the global amblyopia treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America accounts for the largest market share due to the presence of key manufacturers of the product is high and, increasing research and development activities, healthcare expenditure.
Asia-Pacific is dominating the market due to increased new research and developments on amblyopia treatment market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Amblyopia Treatment Market Share Analysis
The global amblyopia treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global amblyopia treatment market
Key players operating in the global amblyopia treatment market include:
- Novartis AG (Switzerland)
- Abbvie,Inc (U.S.)
- Bausch Health Companies Inc (Canada)
- Integra LifeSciences (U.S.)
- Alcon (U.S.)
- Astellas Pharma Inc. (Japan)
- Takeda Pharmaceutical Company Limited (Japan)
- Vertex Pharmaceuticals Incorporated (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Fresnel Prism and Lens Co (U.S.)
- Lancastle International Ltd (U.K.)
- Good-Lite (Scotland)
- RevitalVision (U.S.)
- Vivid Vision, Inc (U.S.)
SKU-